Tamper-evident pharmaceutical packaging using adhesive

System comparison between classic hotmelt application, two-shot procedure and the use of reactive PUR Hotmelt.

The EU Directive 2011/62, known as the Falsified Medicines Directive, requires pharmaceutical companies to ensure that prescription medicines can only be released for sale if they are equipped with at least two safety features. They serve to verify the authenticity of the individual packaging and provide evidence of tampering. Only after positive identification may pharmacies deliver the goods to the patient.  

To read the full article. Please click here.